Two Antifungal Components Isolated from Fructus Psoraleae and Folium Eucalypti Globuli by Bioassay-Guided Purification

被引:30
作者
Lau, Kit-Man [1 ]
Fu, Lai-Hong [2 ]
Cheng, Ling [1 ]
Wong, Chun-Wai [1 ]
Wong, Yin-Lai [1 ]
Lau, Ching-Po [1 ]
Han, Simon Quan-Bin [1 ]
Chan, Paul Kay-Sheung [2 ]
Fung, Kwok-Pui [1 ,3 ]
Lau, Clara Bik-San [1 ]
Hui, Mamie [2 ]
Leung, Ping-Chung [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 2010年 / 38卷 / 05期
关键词
Psoralea corylifolia; Eucalyptus globules; Bakuchiol; Macrocarpal C; Antifungal; Dermatophyte; ANTIMICROBIAL ACTIVITIES; BAKUCHIOL; TERBINAFINE; EXTRACTS; FABACEAE; FOOT;
D O I
10.1142/S0192415X10008421
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Fructus Psoraleae and Folium Eucalypti Globuli have long been used as Chinese medicines to treat various ailments such as asthma, eczema and dermatomycosis. In previous studies, their antifungal activities were demonstrated. The aim of the present study was to isolate active antidermatophytic compounds from their ethanolic extracts by means of bioassay-guided purification. Guided by the inhibitory activities on Trichophyton mentagrophytes, Trichophyton rubrum and Paecilomyces variolii, bakuchiol was isolated from the n-hexane fraction of Fructus Psoraleae whilst macrocarpal C was isolated from the n-hexane fraction of Folium Eucalypti Globuli. Both pure compounds could effectively inhibit the growth of dermatophytes in vitro. This is the first paper to report the isolation and identification of active antidermatophytic compounds from Fructus Psoraleae and Folium Eucalypti Globuli by the bioassay-guided purification.
引用
收藏
页码:1005 / 1014
页数:10
相关论文
共 26 条
[11]   Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria [J].
Nagata, H ;
Inagaki, Y ;
Yamamoto, Y ;
Maeda, K ;
Kataoka, K ;
Osawa, K ;
Shizukuishi, S .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2006, 21 (03) :159-163
[12]   Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study [J].
Ortonne, J. P. ;
Koring, H. C. ;
Viguie-Vallanet, C. ;
Larnier, C. ;
Savaluny, E. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (10) :1307-1313
[13]   Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine [J].
Osborne, CS ;
Leitner, I ;
Hofbauer, B ;
Fielding, CA ;
Favre, B ;
Ryder, NS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2234-2236
[14]   Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine [J].
Osborne, CS ;
Leitner, I ;
Favre, B ;
Ryder, NS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2840-2844
[15]   Antidermatophytic activity of extracts from Psoralea corylifolia (Fabaceae) correlated with the presence of a flavonoid compound [J].
Prasad, NR ;
Anandi, C ;
Balasubramanian, S ;
Pugalendi, KV .
JOURNAL OF ETHNOPHARMACOLOGY, 2004, 91 (01) :21-24
[16]  
PRIKHOD'KO V A, 1980, Mikrobiologicheskii Zhurnal (Kiev), V42, P646
[17]  
PRIKHOD'KO V A, 1979, Mikrobiologicheskii Zhurnal (Kiev), V41, P400
[18]   SUCCESSFUL TREATMENT OF CHRONIC TINEA PEDIS (MOCCASIN TYPE) WITH TERBINAFINE (LAMISIL) [J].
SAVIN, R .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1989, 14 (02) :116-119
[19]   Updates on the Epidemiology of Dermatophyte Infections [J].
Seebacher, Claus ;
Bouchara, Jean-Philippe ;
Mignon, Bernard .
MYCOPATHOLOGIA, 2008, 166 (5-6) :335-352
[20]  
*STAT PHARM COMM P, 2005, PHARM PEOPL REP CHIN, V1, P107